Friday 6 November 2026
Export VSEE’s income statement to Excel — free account
VSee Health, Inc.
VSEE Healthcare Health Information Services
VSee Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.6 million, up 40.3% from fiscal 2024.
- Revenue
- −53.9%
- EPS
- +109.9%
- Free cash flow
- −257.6%
- Total debt
- +31.6%
Quarter to June 2026, against a year earlier
1.15
0.00
0.00%
Follow VSEE
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 4 | — | — |
+8 more TTM periods Free account |
| (1,065.78%) | (945.70%) | (541.52%) | 2,466.75% | ||
| (56.62%) | (69.53%) | (69.39%) | (46.05%) | ||
ROIC |
(93.65%) | (116.45%) | (602.00%) | 0.00% | |
Return on Tangible Assets |
209.77% | 199.66% | 193.99% | 52.22% | |
Average Days of Receivables |
64.48 | 67.44 | 55.96 | 65.24 | |
Free Cash Flow per Share |
(9.40) | (9.21) | (13.86) | (21.93) | |
Free Cash Flow |
(6.31) | (5.52) | (3.49) | (4.54) | |
Capital Expenditures |
— | (0.06) | (0.05) | (0.04) | |
| Other line items | |||||
Cash ROIC |
(71.43%) | (65.31%) | (31.46%) | 100.53% | |
Accounts Receivable Turnover |
6.56 | 6.39 | 7.39 | 5.56 | |
Accounts Payable Turnover |
1.08 | 0.86 | 0.78 | 0.52 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
269.01 | 401.06 | 468.95 | 828.44 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.01) | 0.00 | 0.22 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
143.74% | 120.50% | 115.87% | 106.19% | |
Share Based Compensation of Revenue |
7.95% | 8.12% | 7.69% | 8.02% | |
Interest Coverage |
(5.78) | (4.89) | (3.41) | (5.83) | |
Operating CF/Net income |
0.64 | 0.41 | 0.23 | 0.45 | |
Depreciation/Fixed assets |
23.09 | 9.94 | 9.00 | 6.48 | |
Capex/Depreciation |
0.00 | (0.02) | (0.02) | (0.02) | |
Revenue per Share |
18.83 | 24.14 | 58.06 | 69.73 | |
Operating CF per Share |
(9.40) | (9.11) | (13.68) | (21.72) | |
Capex per Share |
0.00 | (0.10) | (0.18) | (0.21) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026